Sabrina Pelliccia | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Correctly marking the 70th anniversary of Castleman disease-Response	BRITISH JOURNAL OF HAEMATOLOGY	2024
Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study	JOURNAL OF CLINICAL MEDICINE	2023
Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's disease	FRONTIERS IN ONCOLOGY	2023
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas	HEMATOLOGICAL ONCOLOGY	2023
The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features	BRITISH JOURNAL OF HAEMATOLOGY	2023
Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162	JOURNAL OF CLINICAL MEDICINE	2023
Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma	JOURNAL OF CLINICAL MEDICINE	2022
IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study	LEUKEMIA	2022
[18F]FDG PET/CT in Patients Affected by SARS-CoV-2 and Lymphoproliferative Disorders and Treated with Tocilizumab	JOURNAL OF PERSONALIZED MEDICINE	2022
Arrhythmias and cardiogenic shock: a rare disease presentation of diffuse large B-cell lymphoma with cardiac involvement	HEMATO	2021
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study	IN VIVO	2020
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma	CANCER CHEMOTHERAPY AND PHARMACOLOGY	2020
Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation	BONE MARROW TRANSPLANTATION	2019
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma	INVESTIGATIONAL NEW DRUGS	2019
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma. a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)	LEUKEMIA & LYMPHOMA	2019
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients	ONCOIMMUNOLOGY	2015